Cigarette smoking, oral moist snuff use and glucose intolerance

被引:117
作者
Persson, PG
Carlsson, S
Svanström, L
Östenson, CG
Efendic, S
Grill, V
机构
[1] Karolinska Hosp, Stockholm Cty Council, Div Epidemiol, S-10401 Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
[3] Karolinska Inst, Dept Mol Med, S-10401 Stockholm, Sweden
[4] Karolinska Inst, Dept Publ Hlth Sci, S-10401 Stockholm, Sweden
关键词
cigarettes; epidemiological study; glucose intolerance; tobacco use; type; 2; diabetes;
D O I
10.1046/j.1365-2796.2000.00708.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the association between cigarette smelting and use of oral moist snuff and impaired glucose tolerance and type 2 diabetes. Design. We performed a population-based cross-sectional study of glucose intolerance and tobacco use in Stockholm during 1992-94. The sample consisted of 3128 men, aged 35-56 years, of whom 52% had a family history of diabetes. In an oral glucose tolerance test, we detected 55 men with type 2 diabetes and 172 with impaired glucose tolerance. Information on cigarette smoking and oral moist snuff use was collected by a questionnaire. Results. The odds ratio of type 2 diabetes was increased for smokers of 25+ cigarettes day(-1) (odds ratio = 2.6, 95% confidence interval = 1.1-5.9) as well as for moist snuff dippers of 3+ boxes week(-1) (odds ratio = 2.7, 95% confidence interval = 1.3-5.5). The odds ratio of relatively high (highest tertile) fasting insulin levels in subjects with impaired glucose tolerance associated with cigarette smoking of 25+ cigarettes day(-1) was 1.5 (95% confidence interval = 0.7-3.6). The corresponding estimate of a relatively low (lowest tertile) 2 h insulin response was 2.5 (95% confidence interval = 0.9-7.1). Conclusions. These results indicate that heavy users of cigarettes or moist snuff have an increased risk of type 2 diabetes. The results could suggest that tobacco use is associated with a low insulin response.
引用
收藏
页码:103 / 110
页数:8
相关论文
共 30 条
[1]  
[Anonymous], WHO TECHN REP SER
[2]   SMOKING INDUCES INSULIN RESISTANCE - A POTENTIAL LINK WITH THE INSULIN RESISTANCE SYNDROME [J].
ATTVALL, S ;
FOWELIN, J ;
LAGER, I ;
VONSCHENCK, H ;
SMITH, U .
JOURNAL OF INTERNAL MEDICINE, 1993, 233 (04) :327-332
[3]   Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users [J].
Bolinder, G ;
de Faire, U .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (10) :1153-1163
[4]   SMOKELESS TOBACCO USE AND INCREASED CARDIOVASCULAR MORTALITY AMONG SWEDISH CONSTRUCTION WORKERS [J].
BOLINDER, G ;
ALFREDSSON, L ;
ENGLUND, A ;
DEFAIRE, U .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (03) :399-404
[5]  
Bolinder G, 1997, Lakartidningen, V94, P3725
[6]  
Carlsson S, 1998, AM J EPIDEMIOL, V148, P539, DOI 10.1093/oxfordjournals.aje.a009679
[7]   Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance [J].
Eliasson, B ;
Taskinen, MR ;
Smith, U .
CIRCULATION, 1996, 94 (05) :878-881
[8]   THE INSULIN-RESISTANCE SYNDROME IN SMOKERS IS RELATED TO SMOKING-HABITS [J].
ELIASSON, B ;
ATTVALL, S ;
TASKINEN, MR ;
SMITH, U .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (12) :1946-1950
[9]   CARDIOVASCULAR RISK-FACTORS IN YOUNG SNUFF-USERS AND CIGARETTE SMOKERS [J].
ELIASSON, M ;
LUNDBLAD, D ;
HAGG, E .
JOURNAL OF INTERNAL MEDICINE, 1991, 230 (01) :17-22
[10]   RELATIONSHIP OF CIGARETTE-SMOKING AND SNUFF DIPPING TO PLASMA-FIBRINOGEN, FIBRINOLYTIC VARIABLES AND SERUM-INSULIN - THE NORTHERN SWEDEN MONICA STUDY [J].
ELIASSON, M ;
ASPLUND, K ;
EVRIN, PE ;
LUNDBLAD, D .
ATHEROSCLEROSIS, 1995, 113 (01) :41-53